HyperRHO® S/D Prevention of Rh Hemolytic Disease of the …
HyperRHO® S/D Full Dose (Rh o [D] immune globulin [human]) is indicated for the prevention of Rh HDN and the prevention of isoimmunization in Rh o (D)-negative individuals who have been transfused with Rh o (D)-positive blood or blood components containing red blood cells.
HyperRHO® S/D Ordering Info | Prevention of Rh HDN
HyperRHO ® S/D Full Dose (Rh O [D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh O (D) negative individuals who have been transfused with Rh O (D) positive red blood cells.
About Grifols | HyperRHO® S/D for Prevention of Rh HDN
HyperRHO ® S/D Full Dose (Rh O [D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh O (D) negative individuals who have been transfused with Rh O (D) positive red blood cells.
Contact Us | HyperRHO® S/D for Prevention of Rh HDN
HyperRHO ® S/D Full Dose (Rh O [D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh O (D) negative individuals who have been transfused with Rh O (D) positive red blood cells.
HyperRHO S/D Full Dose is made from human plasma. Products made from human plasma may contain infectious agents, such as viruses, and, theoretically, the Creutzfeldt-Jakob Disease (CJD) agent that can cause disease. The risk that such products will transmit an infectious agent has
Hemolytic Disease of the Newborn (HDN) Resources for HCP
HyperRHO ® S/D Full Dose (Rh O [D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh O (D) negative individuals who have been transfused with Rh O (D) positive red blood cells.
Hemolytic Disease of the Newborn (HDN) - HyperRHO
HyperRHO ® S/D Full Dose (Rh O [D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh O (D) negative individuals who have been transfused with Rh O (D) positive red blood cells.
HyperRHO® S/D Full Dose (Rh o[D] immune globulin [human]) is indicated for prevention of Rh hemolytic disease of the newborn (HDN) and the prevention of isoimmunization in Rh o(D) negative individuals who have been transfused with Rh o(D) positive red blood cells.
Request a Representative - hyperrho.com
Your local representative can provide you with more information about HyperRHO S/D. Submit a request below. All fields required.
Causes of Rh D Alloimmunization. Rh D alloimmunization occurs when a Rh D-negative woman is exposed to red cells expressing the Rh D antigen. Although the fetal and maternal circulations are separate, there is often some antenatal mixing of fetal …